HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The use of the Toxin Binding Inhibition (ToBI) test for the estimation of the potency of the diphtheria component of vaccines.

Abstract
The Toxin Binding Inhibition (ToBI) test, previously developed for the estimation of diphtheria and tetanus antitoxin in human sera, was adapted for the estimation of the potency of diphtheria components in vaccines. Data are presented to show that antitoxin titres of individual sera of mice obtained by the ToBI test are in good agreement with those obtained in the Vero cell test. In addition, diphtheria potency and 95% confidence interval of twelve batches of vaccine in different compositions were estimated by the ToBI test and the results were compared with those obtained in Vero cells. A significant correlation could be demonstrated. It is concluded from this study that the ToBI test is a valuable model in the potency assay of diphtheria toxoids, based on antitoxin induction in mice.
AuthorsC F Hendriksen, J W van den Gun, J G Kreeftenberg
JournalJournal of biological standardization (J Biol Stand) Vol. 17 Issue 3 Pg. 241-7 (Jul 1989) ISSN: 0092-1157 [Print] England
PMID2793876 (Publication Type: Journal Article)
Chemical References
  • Diphtheria Toxin
  • Diphtheria Toxoid
Topics
  • Animals
  • Diphtheria Toxin (immunology)
  • Diphtheria Toxoid (immunology)
  • Female
  • Male
  • Mice
  • Reproducibility of Results
  • Vero Cells

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: